0001694665-23-000119.txt : 20230712
0001694665-23-000119.hdr.sgml : 20230712
20230712160815
ACCESSION NUMBER: 0001694665-23-000119
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230711
FILED AS OF DATE: 20230712
DATE AS OF CHANGE: 20230712
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Reynolds Alexander C
CENTRAL INDEX KEY: 0001984687
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38473
FILM NUMBER: 231084300
MAIL ADDRESS:
STREET 1: C/O EVELO BIOSCIENCES, INC.
STREET 2: 620 MEMORIAL DRIVE, SUITE 200
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Evelo Biosciences, Inc.
CENTRAL INDEX KEY: 0001694665
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 465594527
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 620 MEMORIAL DRIVE SUITE 500
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-577-0300
MAIL ADDRESS:
STREET 1: 620 MEMORIAL DRIVE SUITE 500
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
wk-form4_1689192483.xml
FORM 4
X0407
4
2023-07-11
0
0001694665
Evelo Biosciences, Inc.
EVLO
0001984687
Reynolds Alexander C
C/O EVELO BIOSCIENCES, INC.
620 MEMORIAL DRIVE
CAMBRIDGE
MA
02139
1
0
0
0
0
Stock Option (Right to Buy)
3.38
2023-07-11
4
A
0
2000
0
A
2033-07-11
Common Stock
2000
2000
D
The option vests in 36 substantially equal monthly installments following the grant date and has a term of 10 years.
On June 29, 2023, the Issuer effected a 1-for-20 reverse stock split. The share counts herein have been adjusted to reflect the reverse stock split.
/s/ Marella Thorell, Attorney-in-Fact for Alexander C. Reynolds
2023-07-12